The logarithm of the triglyceride/HDL-cholesterol ratio is related to the history of cardiovascular disease in patients with familial hypercholesterolemia

Baigent, 2005, Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins, Lancet, 366, 1267, 10.1016/S0140-6736(05)67394-1 Gordon, 1977, High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study, Am J Med, 62, 707, 10.1016/0002-9343(77)90874-9 Gardner, 1996, Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women, JAMA, 276, 875, 10.1001/jama.1996.03540110029028 Stampfer, 1996, A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction, JAMA, 276, 882, 10.1001/jama.1996.03540110036029 Lamarche, 1997, Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study, Circulation, 95, 69, 10.1161/01.CIR.95.1.69 Tribble, 1992, Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size, Arteriosclerosis, 93, 189, 10.1016/0021-9150(92)90255-F Toyota, 1999, Low density lipoprotein (LDL) binding affinity for the LDL receptor in hyperlipoproteinemia, Atherosclerosis, 147, 77, 10.1016/S0021-9150(99)00166-5 Galeano, 1994, Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size, J Biol Chem, 269, 511, 10.1016/S0021-9258(17)42379-9 Campos, 1992, Low density lipoprotein particle size and coronary artery disease, Arterioscler Thromb, 12, 187, 10.1161/01.ATV.12.2.187 Blanche, 1981, Characterization of human high-density lipoproteins by gradient gel electrophoresis, Biochim Biophys Acta, 665, 408, 10.1016/0005-2760(81)90253-8 Stein, 1999, Atheroprotective mechanisms of HDL, Atherosclerosis, 144, 285, 10.1016/S0021-9150(99)00065-9 Lamarche, 1997, Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study, Arterioscler Thromb Vasc Biol, 17, 1098, 10.1161/01.ATV.17.6.1098 Roheim, 1995, Clinical significance of lipoprotein size and risk for coronary atherosclerosis, Clin Chem, 41, 147, 10.1093/clinchem/41.1.147 Sweetnam, 1994, Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies, Circulation, 90, 769, 10.1161/01.CIR.90.2.769 Salonen, 1991, HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men, Circulation, 84, 129, 10.1161/01.CIR.84.1.129 Soedamah-Muthu, 2003, Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study, Diabetologia, 46, 674, 10.1007/s00125-003-1094-8 Williams, 1992, Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women, Arterioscler Thromb, 12, 332, 10.1161/01.ATV.12.3.332 Freedman, 1998, Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease, Arterioscler Thromb Vasc Biol, 18, 1046, 10.1161/01.ATV.18.7.1046 Lamarche, 1999, HDL metabolism in hypertriglyceridemic states: an overview, Clin Chim Acta, 286, 145, 10.1016/S0009-8981(99)00098-4 Ohta, 1997, Fractional esterification rate of cholesterol in high density lipoprotein is correlated with low density lipoprotein particle size in children, J Lipid Res, 38, 139, 10.1016/S0022-2275(20)37283-7 Dobiasova, 2001, The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FERHDL), Clin Biochem, 34, 583, 10.1016/S0009-9120(01)00263-6 Dobiasova, 2011, Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography, J Lipid Res, 52, 566, 10.1194/jlr.P011668 Dobiasova, 1991, Cholesterol esterification rates in very low density lipoprotein- and low density lipoprotein-depleted plasma. Relation to high density lipoprotein subspecies, sex, hyperlipidemia, and coronary artery disease, Arterioscler Thromb, 11, 64, 10.1161/01.ATV.11.1.64 Dobiasova, 1994, Structural and functional assessment of high-density lipoprotein heterogeneity, Clin Chem, 40, 1554, 10.1093/clinchem/40.8.1554 Dobiasova, 1996, Measurement of fractional esterification rate of cholesterol in plasma depleted of apoprotein B containing lipoprotein: methods and normal values, Physiol Res, 45, 65 Dobiasova, 1998, Assays of lecithin cholesterol acyltransferase (LCAT), 217 Dobiasova, 2000, Effect of labeling of plasma lipoproteins with [(3)H]cholesterol on values of esterification rate of cholesterol in apolipoprotein B-depleted plasma, J Lipid Res, 41, 1356, 10.1016/S0022-2275(20)33444-1 Frohlich, 2003, Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography, Clin Chem, 49, 1873, 10.1373/clinchem.2003.022558 Gaziano, 1997, Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction, Circulation, 96, 2520, 10.1161/01.CIR.96.8.2520 Dobiasova, 2005, Relations between particle size of HDL and LDL lipoproteins and cholesterol esterification rate, Physiol Res, 54, 159, 10.33549/physiolres.930565 Dobiásová, 2004, Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications, Clin Chem, 50, 1113, 10.1373/clinchem.2004.033175 Frohlich, 2004, Gender differences in plasma levels of lipoprotein (a) in patients with angiographically proven coronary artery disease, Physiol Res, 53, 481, 10.33549/physiolres.930511 Goldstein, 2001, Familial hypercholesterolemia, 2863 Hogue, 2004, Relationship between cholesteryl ester transfer protein and LDL heterogeneity in familial hypercholesterolemia, J Lipid Res, 45, 1077, 10.1194/jlr.M300420-JLR200 Hogue, 2007, Association of heterozygous familial hypercholesterolemia with smaller HDL particle size, Atherosclerosis, 190, 429, 10.1016/j.atherosclerosis.2006.02.023 de Grooth, 2004, The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia, Atherosclerosis, 173, 261, 10.1016/j.atherosclerosis.2003.11.020 Friedewald, 1972, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499 Goldmann, 2010, Genomic characterization of large rearrangements of the LDLR gene in Czech patients with familial hypercholesterolemia, BMC Med Genet, 11, 115, 10.1186/1471-2350-11-115 Myant, 1993, Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia, Atherosclerosis, 104, 1, 10.1016/0021-9150(93)90171-P Moorjani, 1993, Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia, Lancet, 341, 1303, 10.1016/0140-6736(93)90815-X Williams, 1993, Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics, Am J Cardiol, 72, 171, 10.1016/0002-9149(93)90155-6 Thompson, 1999, Familial hypercholesterolaemia, 673 Soska, 2011, Plasma HDL-cholesterol and triglyceride levels in familial hypercholesterolemia: data from the MedPed CZ database and the Czech population, Clin Chim Acta, 10.1016/j.cca.2011.01.017 Scientific Steering Committee on behalf of the Simon Broome Register Group, 1991, Risk of fatal coronary heart disease in familial hypercholesterolaemia, BMJ, 303, 893, 10.1136/bmj.303.6807.893 de Sauvage Nolting, 2003, Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia, J Intern Med, 253, 161, 10.1046/j.1365-2796.2003.01070.x Ferrières, 1995, Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation, Circulation, 92, 290, 10.1161/01.CIR.92.3.290 Hill, 1991, Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia, Arterioscler Thromb, 11, 290, 10.1161/01.ATV.11.2.290 Sun, 1998, Influence of genotype at the low density lipoprotein (LDL) receptor gene locus on the clinical phenotype and response to lipid-lowering drug therapy in heterozygous familial hypercholesterolaemia, Atherosclerosis, 136, 175, 10.1016/S0021-9150(97)00181-0 Graham, 1999, Mutation screening and genotype: phenotype correlation in familial hypercholesterolemia, Atherosclerosis, 147, 309, 10.1016/S0021-9150(99)00201-4 Wiegman, 2003, Family history and cardiovascular risk in familial hypercholesterolemia. Data in more than 1000 children, Circulation, 107, 1473, 10.1161/01.CIR.0000058166.99182.54 Watts, 2000, Postprandial lipaemia in familial hypercholesterolaemia: clinical and metabolic significance, Atherosclerosis, 148, 426, 10.1016/S0021-9150(99)00467-0 Panagiotakos, 2003, Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987–2002), Curr Med Res Opin, 19, 89 Kolovou, 2010, Familial hypercholesterolemia and triglyceride metabolism, Int J Cardiol Malloy, 2001, A risk factor for atherosclerosis: triglyceride-rich lipoproteins, Adv Intern Med, 47, 111 Kondo, 2001, Relationship between triglyceride concentrations and LDL size evaluated by malondialdehyde-modified LDL, Clin Chem, 47, 893, 10.1093/clinchem/47.5.893 Ohta, 1997, Fractional esterification rate of cholesterol in high density lipoprotein (HDL) can predict the particle size of low density lipoprotein and HDL in patients with coronary heart disease, Atherosclerosis, 135, 205, 10.1016/S0021-9150(97)00163-9 Williams, 2003, Smallest LDL particles are most strongly related to coronary disease progression in men, Arterioscler Thromb Vasc Biol, 23, 314, 10.1161/01.ATV.0000053385.64132.2D Drexel, 1992, Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease, Am J Cardiol, 70, 436, 10.1016/0002-9149(92)91186-8